Skip to content
Friday, May 20, 2022
HealthCare Africa Magazine

Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine

Africa Health & Wellness Expo ad
  • Home
  • TOPICS
    • INVESTMENTS & FUNDING
    • MERGERS & ACQUISITIONS
    • DISEASES UPDATES
    • HEALTHCARE DELIVERY
    • PHARMA MANUFACTURING
    • PEOPLE NEWS
    • CORONAVIRUS NEWS
    • REGULATORY & POLICY
  • THE MAGAZINE
    • About HealthCare Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • VIDEOS
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Bayer to end CAR T-cell therapies collaboration with Atara Biotherapeutics
  • WHO validates CONVIDECIA as 11th vaccine for COVID-19
  • India’s drug regulator approves Boehringer Ingelheim’s cardiac treatment
  • CCI approves Covidshield Technologies, Biocon Biologics merger
  • Aster DM flies higher with Skye Air drone partnership
  • WHO's scorecard shows global health achievements, despite COVID-19 pandemic
  • Pollution caused 1 in 6 deaths globally for five years, study says
  • Aenova invests US$11 mln to expand production of highly potent drugs in Germany
  • Takeda launches Adynovate, a hemophilia drug in India
  • Goldman Sachs expected to invest US$350mln in PharmEasy's parent company
You are here
  • Home
  • Aduhelm

Tag: Aduhelm

Lilly slacks off FDA submission of Alzheimer’s drug after CMS decision on Aduhelm

7 February 20227 February 2022

USA – Eli Lilly has pushed back the deadline for submitting an application for U.S. approval of its experimental Alzheimer’s disease drug, revealing that it will now complete the filing…

Read More

Takeda, Denali’s Alzheimer’s candidate drug hits regulatory drawback

17 January 202217 January 2022

USA – The FDA has placed a clinical hold on Denali Therapeutics’ Alzheimer’s drug before it even enters human trials. The decision has an impact on Takeda, which only recently…

Read More

Becerra tells Medicare to review premiums after Aduhelm cost cut

12 January 202212 January 2022

USA – U.S. Health Secretary Xavier Becerra has directed the Centers for Medicare & Medicaid Services (CMS) to reconsider a hefty 2022 Medicare Part B premium hike proposal based in…

Read More

Biogen mulls massive layoffs following disappointing Aduhelm rollout: Report

14 December 202114 December 2021

USA – Biogen is planning to lay off over 1000 employees following the disappointing launch of its Alzheimer’s therapy Aduhelm (aducanumab), according to STAT News. According to STAT News, Biogen…

Read More

First nasal vaccine against Alzheimer’s disease enters human trial phase

30 November 202130 November 2021

USA – Clinical trial for Alzheimer’s disease (AD) nasal vaccine has been launched to see whether a potential treatment could be safe for humans after the therapy showed positive results…

Read More

Biogen’s Alzheimer’s drug gets negative vote from European regulators

18 November 202118 November 2021

EUROPE – European Medicines Agency (EMA) panel voted against approval of Biogen Inc’s Alzheimer’s drug Aduhelm, dealing another setback to the treatment already grappling with a slow rollout in the…

Read More

Biogen’s pricey Alzheimer’s drug spurs biggest increase in Medicare premium

16 November 202116 November 2021

USA – The federal government has announced a significant increase in Medicare premiums, blaming the pandemic but also citing “uncertainty” about how much it may be forced to pay for…

Read More

Aduhelm drug set to undergo its first real world observational phase 4 study

30 July 202130 July 2021

WORLD – Biogen and Eisai have presented a design of the first real-world observational phase 4 study in Alzheimer’s disease by the name ICARE AD-US. ICARE AD-US, a prospective study…

Read More

FDA’s approval of aduhelm drug marred by controversy following resignations by three FDA panel members

17 July 202118 July 2021

US – Aduhelm was the first of its kind drug for Alzheimer’s disease to be approved in two decades under the accelerated approval by Food & Drug Association (FDA), however,…

Read More

LATEST DIGITAL MAGAZINE

Africa Health & Wellness Expo ad

Popular Posts Recent Posts

AAR Healthcare unveils new ultra-modern 140-bed capacity hospital

Ghanaian startup Yemaachi secures US$3M seed funding to advance cancer research

Lilly announces the Institute for Genetic Medicine and US$700 million investment

FDA OK’s Quantum’s Epione robot for liver cancer

Africa’s journey to healthcare independence, as fueled by effects of the ongoing pandemic

Bayer to end CAR T-cell therapies collaboration with Atara Biotherapeutics

WHO validates CONVIDECIA as 11th vaccine for COVID-19

India’s drug regulator approves Boehringer Ingelheim’s cardiac treatment

CCI approves Covidshield Technologies, Biocon Biologics merger

Aster DM flies higher with Skye Air drone partnership

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Biogen Cancer China COVAX Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS India Investments & Funding Japan Johnson & Johnson Kenya Malaria Manufacturing Merck Mergers & Acquisitions Moderna MOH Kenya Nigeria Novartis Pfizer Pharmaceuticals Roche Sanofi Science & Technology South Africa Switzerland Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Africa MagazineFollow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCare Africa Magazine
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

About 1 billion people globally denied access to assistive products: Report
https://t.co/XdBGynFqHM #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment @WHO @UNICEF

Reply on Twitter 1527549390788902913Retweet on Twitter 15275493907889029131Like on Twitter 15275493907889029131Twitter 1527549390788902913
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

#Aenova Group invests US$11 mln to expand production of highly potent drugs in Germany
https://t.co/cRRWxBANAr #healthtech #innovation #healthcaredelivery #science #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1527546192435064832Retweet on Twitter 1527546192435064832Like on Twitter 1527546192435064832Twitter 1527546192435064832
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

Pollution caused 1 in 6 deaths globally for five years, study says
https://t.co/Wt2uRe1DHA #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #airpollution

Reply on Twitter 1527544485231607808Retweet on Twitter 1527544485231607808Like on Twitter 1527544485231607808Twitter 1527544485231607808
Retweet on TwitterHealthCare Africa Magazine Retweeted
OliveMugendaProf. Olive Mugenda Ph.D MGH@OliveMugenda·
May 18, 2022

The Cath-Lab at KUTRRH is now ready for commissioning. Cath-Lab is a specialised lab that deals with diagnosing blockages within the heart, unblocking as well as performing other interventions like cardiac pacemaker placements.
A great milestone for KUTRRH, MoH and Kenyans.

4
Reply on Twitter 1526921388057051137Retweet on Twitter 152692138805705113727Like on Twitter 1526921388057051137115Twitter 1526921388057051137
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Health and wellness startup @FlexifyMe raises US$300K in seed round
https://t.co/vyCRnHxiil #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #wellness #startup

Reply on Twitter 1526125167860146177Retweet on Twitter 1526125167860146177Like on Twitter 1526125167860146177Twitter 1526125167860146177
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa magazine

Food Business Africa magazine

Food Safety Africa magazine

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.